{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:17:56Z","timestamp":1791605876732,"version":"4.3.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical application of cardiovascular disease (CVD) biomarkers requires robust biological variation (BV) data to enable both interpretation of serial results and definition of appropriate analytical quality. A critical review and meta-analysis of eligible BV studies of natriuretic peptides and other CVD-related biomarkers was therefore undertaken, with a focus on differences observed in different states of health and the impact of sampling intervals on BV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BV studies of N-terminal pro\u2013B-type natriuretic peptide (NT-proBNP), brain natriuretic peptide, N-terminal pro\u2013A-type natriuretic peptide, galectin, copeptin, soluble suppression of tumorigenicity-2, and growth differentiation factor 15 were identified by a systematic literature review and assessed using the Biological Variation Data Critical Appraisal Checklist. A meta-analysis of eligible studies was used to derive within-subject (CVI) and between-subject BV estimates, which were used to calculate analytical performance specifications, indices of individuality, and reference change values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one studies were identified, only 3 of which achieved an A grade on the Biological Variation Data Critical Appraisal Checklist, indicating full checklist compliance. For NT-proBNP, meta-analysis\u2013derived CVI estimates depended on sampling frequencies and study duration: &amp;lt;15 days (9.9%; 95% CI, 8.8\u201318.0) and &amp;gt;15 days (34.3%; 95% CI, 25.0\u201360.0). For the other biomarkers, from one to 5 BV studies were identified, reporting on different states of health and sampling intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review provides quality-assessed BV data for natriuretic peptides and other CVD markers. Our results highlight the influence of sampling frequency on CVI for NT-proBNP, potentially impacting the intended use. Further BV studies applicable to multiple clinical scenarios are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvag051","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:37:39Z","timestamp":1776944259000},"page":"857-867","source":"Crossref","is-referenced-by-count":1,"title":["Biological Variation of Natriuretic Peptides and Other Cardiovascular Disease-Related Biomarkers: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"72","author":[{"given":"Pilar","family":"Fern\u00e1ndez-Calle","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, La Paz University Hospital , Madrid ,","place":["Spain"]},{"name":"IdiPaz\u2014Hospital La Paz Institute for Health Research , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-1505","authenticated-orcid":false,"given":"Jorge","family":"D\u00edaz-Garz\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, La Paz University Hospital , Madrid ,","place":["Spain"]},{"name":"IdiPaz\u2014Hospital La Paz Institute for Health Research , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Undergraduate Teaching, School of Medicine, University of Dundee , Dundee ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-0604","authenticated-orcid":false,"given":"Abdurrahman","family":"Coskun","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ruhr University Bochum, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum , Bochum ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Carobene","sequence":"additional","affiliation":[{"name":"Servizio Medicina di Laboratorio, Ospedale San Raffaele , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Gonz\u00e1lez-Lao","sequence":"additional","affiliation":[{"name":"Quality Department, Consorci Sanitari de Terrassa , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-4003","authenticated-orcid":false,"given":"Fernando","family":"Marqu\u00e9s-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Laboratori Cl\u00ednic Metropolitana Nord, Germans Trias i Pujol University Hospital , Badalona, Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Sufrate-Vergara","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, La Paz University Hospital , Madrid ,","place":["Spain"]},{"name":"IdiPaz\u2014Hospital La Paz Institute for Health Research , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-2066","authenticated-orcid":false,"given":"Isabel","family":"Moreno-Parro","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, La Paz University Hospital , Madrid ,","place":["Spain"]},{"name":"IdiPaz\u2014Hospital La Paz Institute for Health Research , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Galior","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1219-6368","authenticated-orcid":false,"given":"Denis \u0130lhan","family":"Topcu","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, \u0130zmir City Hospital , \u0130zmir ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital , Bergen ,","place":["Norway"]},{"name":"Department of Global Public Health and Primary Care, University of Bergen , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-8398","authenticated-orcid":false,"given":"Aasne K","family":"Aarsand","sequence":"additional","affiliation":[{"name":"Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital , Bergen ,","place":["Norway"]},{"name":"Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2026080309514221500_hvag051-B1","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2026080309514221500_hvag051-B2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ehjqcco\/qcad031","article-title":"Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries","volume":"10","author":"Luengo-Fernandez","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080309514221500_hvag051-B3","author":"National Center for Health Statistics"},{"key":"2026080309514221500_hvag051-B4","author":"National Center for Health Statistics"},{"key":"2026080309514221500_hvag051-B5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1515\/dx-2023-0089","article-title":"Diagnostic properties of natriuretic peptides and opportunities for personalized thresholds for detecting heart failure in primary care","volume":"10","author":"Harskamp","year":"2023","journal-title":"Diagnosis"},{"key":"2026080309514221500_hvag051-B6","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/ehf2.14471","article-title":"The cost-effectiveness of NT-proBNP for assessment of suspected acute heart failure in the emergency department","volume":"10","author":"Walkley","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026080309514221500_hvag051-B7","doi-asserted-by":"crossref","first-page":"e940641","DOI":"10.12659\/MSM.940641","article-title":"The diagnostic accuracy of N-terminal pro-B-type natriuretic peptide and soluble ST2 for heart failure in chronic kidney disease patients: a comparative analysis","volume":"29","author":"Ma","year":"2023","journal-title":"Med Sci Monit"},{"key":"2026080309514221500_hvag051-B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajem.2023.05.041","article-title":"NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients\u2014a prospective clinical study","volume":"71","author":"Budolfsen","year":"2023","journal-title":"Am J Emerg Med"},{"key":"2026080309514221500_hvag051-B9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2023.08.007","article-title":"Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA trials: biomarkers and risk prediction in stable coronary artery disease. A post-hoc secondary analysis from the ISCHEMIA randomized clinical trial biorepository","volume":"266","author":"Newman","year":"2023","journal-title":"Am Heart J"},{"key":"2026080309514221500_hvag051-B10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.617705","article-title":"Gender-related differences in heart failure biomarkers","volume":"7","author":"Cediel","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026080309514221500_hvag051-B11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2018.08.042","article-title":"Exploring collagen remodeling and regulation as prognosis biomarkers in stable heart failure","volume":"490","author":"Dupuy","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2026080309514221500_hvag051-B12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100527","article-title":"The AHA\/ACC\/HFSA 2022 heart failure guidelines: changing the focus to heart failure prevention","volume":"15","author":"Abovich","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"2026080309514221500_hvag051-B13","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080309514221500_hvag051-B14","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080309514221500_hvag051-B15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080309514221500_hvag051-B16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40119-023-00328-3","article-title":"Summary and comparison of the 2022 ACC\/AHA\/HFSA and 2021 ESC heart failure guidelines","volume":"12","author":"Badger","year":"2023","journal-title":"Cardiol Ther"},{"key":"2026080309514221500_hvag051-B17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026080309514221500_hvag051-B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3399\/bjgp19X702665","article-title":"Diagnosis and management of chronic heart failure: NICE guideline update 2018","volume":"69","author":"Taylor","year":"2019","journal-title":"Br J Gen Pract"},{"key":"2026080309514221500_hvag051-B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/cclm-2016-0091","article-title":"Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference","volume":"55","author":"Ceriotti","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2026080309514221500_hvag051-B20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/hvaa233","article-title":"Personalized reference intervals in laboratory medicine: a new model based on within-subject biological variation","volume":"67","author":"Co\u015fkun","year":"2021","journal-title":"Clin Chem"},{"key":"2026080309514221500_hvag051-B21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1373\/clinchem.2017.281808","article-title":"The biological variation data critical appraisal checklist: a standard for evaluating studies on biological variation","volume":"64","author":"Aarsand","year":"2018","journal-title":"Clin Chem"},{"key":"2026080309514221500_hvag051-B22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/clinchem\/hvaa261","article-title":"Biological variation of cardiac troponins in health and disease: a systematic review and meta-analysis","volume":"67","author":"Diaz-Garzon","year":"2021","journal-title":"Clin Chem"},{"key":"2026080309514221500_hvag051-B23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cca.2019.05.013","article-title":"Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC)","volume":"495","author":"D\u00edaz-Garz\u00f3n","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2026080309514221500_hvag051-B24","first-page":"157","volume-title":"Tietz textbook of clinical chemistry and molecular biology","author":"Fraser","year":"2017","edition":"6th Ed"},{"key":"2026080309514221500_hvag051-B25","author":"Aarsand"},{"key":"2026080309514221500_hvag051-B26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ Res"},{"key":"2026080309514221500_hvag051-B27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026080309514221500_hvag051-B28","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1001\/archinte.1997.00440400092011","article-title":"Quality of care for elderly patients hospitalized with heart failure","volume":"27","author":"Krumholz","year":"1997","journal-title":"Arch Intern Med"},{"key":"2026080309514221500_hvag051-B29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/cclm-2013-1088","article-title":"Long-term biological variability of galectin-3 after heart transplantation","volume":"53","author":"Franekov\u00e1","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2026080309514221500_hvag051-B30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ejhf.669","article-title":"Variability of biomarkers in patients with chronic heart failure and healthy controls","volume":"19","author":"Meijers","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026080309514221500_hvag051-B31","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1515\/cclm-2023-0673","article-title":"Week-to-week within-subject and between-subject biological variation of copeptin","volume":"62","author":"Guldhaug","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2026080309514221500_hvag051-B32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jalm\/jfae005","article-title":"Biological variation estimates for plasma copeptin and clinical implications","volume":"9","author":"Choy","year":"2024","journal-title":"J Appl Lab Med"},{"key":"2026080309514221500_hvag051-B33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9149(03)00741-0","article-title":"Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure","volume":"92","author":"Wu","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026080309514221500_hvag051-B34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s43044-023-00401-1","article-title":"Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure","volume":"75","author":"Manh","year":"2023","journal-title":"Egypt Heart J"},{"key":"2026080309514221500_hvag051-B35","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07420528.2017.1366500","article-title":"Seasonal variability of NT-proBNP in Swedish primary care patients","volume":"34","author":"Khezri","year":"2017","journal-title":"Chronobiol Int"},{"key":"2026080309514221500_hvag051-B36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1373\/clinchem.2013.209353","article-title":"Week-to-week biological variation in the N-terminal prohormone of brain natriuretic peptide in hemodialysis patients and healthy individuals","volume":"59","author":"Aakre","year":"2013","journal-title":"Clin Chem"},{"key":"2026080309514221500_hvag051-B37","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jacc.2021.03.291","article-title":"Chronobiology of natriuretic peptides and blood pressure in lean and obese individuals","volume":"77","author":"Parcha","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026080309514221500_hvag051-B38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029110","article-title":"NT-proBNP and all-cause and cardiovascular mortality in US adults: a prospective cohort study","volume":"12","author":"Echouffo-Tcheugui","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026080309514221500_hvag051-B39","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","volume":"43","author":"Von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"key":"2026080309514221500_hvag051-B40","first-page":"18","article-title":"Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis","volume":"3","author":"Raskovalova","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080309514221500_hvag051-B41","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/cvr\/cvae214","article-title":"GDF-15 antagonism limits severe heart failure and prevents cardiac cachexia","volume":"120","author":"Takaoka","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2026080309514221500_hvag051-B42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCHEARTFAILURE.112.000129","article-title":"Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH","volume":"6","author":"van der Velde","year":"2013","journal-title":"Circ Heart Fail"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/8\/857\/68514345\/hvag051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/8\/857\/68514345\/hvag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:51:54Z","timestamp":1785765114000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/8\/857\/8706515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvag051","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,6,11]]}}}